Radiosensitization by Nickel Lapachol

References

• Adams G.E., Clarke E.D., Flockhart I.R., Jacobs R.S., Sehmi D.S., Stratford I.J., Wardman P., Watts M.E., Parrick J., Wallace R.G., Smithen C.E. Structure — activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency. International Journal of Radiation Biology 1979a; 35: 133–150
   Web of Science ®Google Scholar
• Adams G.E., Clarke E.D., Gray P., Jacobs R.S., Sehmi D.S., Stratford I.J., Wardman P., Watts M.E., Parrick J., Wallace R.G., Smithen C.E. Structure — activity relationships in the development of hypoxic cell radiosensitizers. II. Cytotoxicity and therapeutic ratio. International Journal of Radiation Biology 1979b; 35: 151–160
   Web of Science ®Google Scholar
• Adams G.E., Cooke M.S. Electron affinic sensitization, I. A structural basis for chemical radiosensitisers in bacteria. International Journal of radiation Biology 1969; 15: 457–471
   Web of Science ®Google Scholar
• Ashnagar A., Bruce J.M., Dutton P.L., Prince R.C. One- and two-electron reduction of hydroxy-1,4-naphthoquinones and hydroxy-9,10-anthraquinones: the role of internal hydrogen bonding and its bearing on the redox chemistry of the anthracycline antitumour quinones. Biochimica et Biophysica Acta 1984; 801: 351–359
   PubMed Web of Science ®Google Scholar
• Banjar Z.M., Hnilica L.S., Briggs R.C., Stein J., Stein G. Cis- and trans-diammine-dichloroplatinum (II)-mediated cross-linking of chromosomal non-histone proteins to DNA in HeLa cells. Biochemistry 1984; 23: 1921–1928
   PubMed Web of Science ®Google Scholar
• Boothman D.A., Greer S., Pardee A.B. Potentiation of halogenated pyrimidine radiosensitizers in human carcinoma cells by β-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione), a novel DNA repair inhibitor. Cancer Research 1987; 47: 5361–5366
   PubMed Web of Science ®Google Scholar
• Boothman D.A., Trask D.K., Pardee A.B. Inhibition of potentially lethal DNA damage repair in human tumor cells by β-lapachone, an activator of topoisomerase I. Cancer Research 1989; 49: 605–612
   PubMed Web of Science ®Google Scholar
• Dewitt L. Combined treatment of radiation and cis-diamminedichloroplatinum (II): a review of experimental and clinical data. International Journal of Radiation Oncology, Biology and Physics 1987; 13: 403–426
   PubMed Web of Science ®Google Scholar
• Dufresne A., De Lima C.G., Knudsen J., Moreira J.E. Chemical and spectral studies of the products of some 2-hydroxy-1,4-naphthoquinones with iron. Journal of Inorganic and Nuclear Chemistry 1973; 35: 789–797
   Web of Science ®Google Scholar
• Farrell N. Metal complexes as radiosensitizers. Progress in Clinical Biochemistry and Medicine, M.J. Clarke. Springer-Verlag, Berlin 1989a; 10: 90–109, In
   Google Scholar
• Farrell N. Transition metal complexes as drugs and chemotherapeutic agents. Catalysis by Metal Complexes, B.R. James, R. Ugo. Reidel-Kluwer, Dordrecht 1989b; II: 291–291, In
   Google Scholar
• Fieser L.F., Berliner E., Bondhus F.J., Chang F.C., Dauben W.G., Ettlinger M.G., Fawaz G., Fields M., Fieser M., Heidelberger C., Heymann H., Seligman A.M., Vaughan W.R., Wilson A.G., Wilson E., Wu M., Leffler M.T., Hamlin K.E., Hathaway R.J., Matson E.J., Moore E.E., Moore M.B., Rapala R.T., Zaugg H.E. Naphthoquinone antimalarials. I. General Survey. Journal of the American Chemical Society 1948; 70: 3151–3155
   PubMed Web of Science ®Google Scholar
• Geyer B.P., Smith G.McP. Preparation and properties of some phthiocol inner complexes. Journal of the American Chemical Society 1941; 63: 3071–3075
   Google Scholar
• Greenstock C., Ruddock G.W., Neta P. Pulse radiolysis and ESR studies of the electron-affinic properties of nitroheterocyclic radiosensitizers. Radiation Research 1976; 66: 472–484
   PubMed Web of Science ®Google Scholar
• Heymann H., Fieser L.F. Naphthoquinone antimalarials. XXI. Antisuccinate oxidase activity. Journal of Biological Chemistry 1948; 176: 1359–1362
   PubMed Web of Science ®Google Scholar
• Kido H., Fernelius W.C., Haas C.G., Jr. Coordination complexes XVIII. Formation constraints of some metal salts of hydroxyquinones. Analytica Chimica Acta 1960; 23: 116–123
   Web of Science ®Google Scholar
• Koch C.J., Skov K.A. Enhanced Radiation Sensitivity by preincubation with nitroimidazoles: effect of glutathionedepletion. International Journal of Radiation Oncology Biology and Physics 1994, In press
   Web of Science ®Google Scholar
• Korbelik M., Skov K.A. Inactivation of hypoxic cells by cisplatin and radiation at clinically relevant doses. Radiation Research 1989; 119: 145–156
   PubMed Web of Science ®Google Scholar
• Matthews J.B., Adomat H., Skov K.A. The effect of hypoxia on cytotoxicity, accumulation and DNA binding of cisplatin in Chinese hamster cells. Anti-Cancer Drugs 1993; 4: 463–470
   PubMed Web of Science ®Google Scholar
• McKelvey E.M., Lomedico M., Lu K., Chadwick M., Loo T.L. Dichlorallyl lawsone. Clinical Pharmacology and Therapeutics 1979; 25: 586–590
   PubMedGoogle Scholar
• Meyn R.E., van Ankeren S.C., Jenkins W.T. The induction of DNA-protein crosslinks in hypoxic cells and their possible contribution to cell lethality. Radiation Research 1987; 109: 419–429
   PubMed Web of Science ®Google Scholar
• Moore B.A., Palcic B., Skarsgard L.D. Radiosensitizing and toxic effects of the 2-nitroimidazole Ro-07-0582 in hypoxic mammalian cells. Radiation Research 1976; 67: 459–473
   PubMed Web of Science ®Google Scholar
• O'Hara J.A., Douple E.G., Abrams J.J., Giandomenico C.M., Bradley F.C., McElligott M.A., Caruso F.S. Combined modality treatment with ternary Cu(II) complexes and X-rays. International Journal of Radiation Oncology, Biology and Physics 1992; 22: 607–612
   PubMed Web of Science ®Google Scholar
• O'Hara J.A., Douple E.D., Abrams M.J., Picker D.J., Giandomenico C.M., Vollano J.F. Potentiation of radiation-induced cell kill by synthetic metalloporphyrins. International Journal of Radiation Oncology, Biology and Physics 1989; 16: 1049–1052
   PubMed Web of Science ®Google Scholar
• Olenick J.G. 2-Hydroxy-3-alkyl-1,4-naphthoquinones. Antibiotics Volume V Part 2: Mechanisms of Action of Antieukaryotic and Antiviral Compounds, F.E. Hahn. Springer-Verlag, Berlin 1979; 214–222, In
   Google Scholar
• Palcic B., Faddegon B., Skarsgard L.D. The effect of misonidazole as hypoxic radiosensitizer at low dose. Radiation Research 1984; 100: 340–347
   PubMed Web of Science ®Google Scholar
• Palcic B., Skarsgard L.D. Cytotoxicity of misonidazole and DNA damage in hypoxic mammalian cells. British Journal of Cancer 1978; 37(Suppl. III)54–59
   Google Scholar
• Palcic B., Skarsgard L.D. Reduced oxygen enhancement ratio at low doses of ionizing radiation. Radiation Research 1984; 100: 328–339
   PubMed Web of Science ®Google Scholar
• Patierno S.R., Costa M. DNA-protein cross-links induced by nickel compounds in intact cultured mammalian cells. Chemical and Biological Interactions 1985; 55: 75–91
   PubMed Web of Science ®Google Scholar
• Patierno S.R., Sugiyama M., Basilion J.P., Costa M. Preferential DNA-protein cross-linking by NiCl2 in magnesium-insoluble regions of fractionated Chinese hamster ovary cell chromatin. Cancer Research 1985; 45: 5787–5794
   PubMed Web of Science ®Google Scholar
• Preusch P.C., Suttie J.W. Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase. Archives of Biochemistry and Biophysics 1984; 234: 405–412
   PubMed Web of Science ®Google Scholar
• Prince R.C., Linkletter S.J.G., Dutton P.L. The thermodynamic properties of some commonly used oxidation-reduction mediators, inhibitors and dyes, as determined by polarography. Biochimica et Biophysica Acta 1981; 635: 132–148
   PubMedGoogle Scholar
• Rao K.V. Quinone natural products: streptonigrin (NSC-45383) and lapachol (NSC-11905) structureactivity relationships. Cancer Chemotherapy Reports 1974; 4: 11–17, Part 2
   Google Scholar
• Rao K.V., McBride T.J., Oleson J.J. Recognition and evaluation of lapachol as an antitumor agent. Cancer Research 1968; 28: 1952–1954
   Web of Science ®Google Scholar
• Rauth A.M., Marshall R.S. Mechanisms of activation of Mitromycin C and AZQ in aerobic and hypoxic mammalian cells. NATO Advanced Research Seminar Series A198. Selective Activation of Drugs by Redox Processes, G.E. Adams, A. Breccia, P. Wardman, E.M. Fielden. Plenum, New York 1990; 113–123, In
   Google Scholar
• Rydberg B. Detection of induced DNA strand breaks with improved sensitivity in human cells. Radiation Research 1980; 81: 492–495
   PubMed Web of Science ®Google Scholar
• Skov K.A. Repair of DNA breaks after irradiation in misonidazole or oxygen. International Journal of Radiation Oncology, Biology and Physics 1984; 10: 1199–1202
   PubMed Web of Science ®Google Scholar
• Skov K.A. Modification of radiation response by metal complexes: a review with emphasis on non-platinum studies. Radiation Research 1987; 112: 217–242
   PubMed Web of Science ®Google Scholar
• Skov K.A. Toxicity of metal complexes with radiosensitizing properties. NATO Advanced Research Seminar Series A198. Selective Activation of Drugs by Redox Processes, G.E. Adams, A. Breccia, P. Wardman, E.M. Fielden. Plenum, New York 1990; 263–273, In
   Google Scholar
• Skov K.A., Adomat H., Farrell N.P. Effects of nickel-lapachol in hypoxic cells. Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy, M. Nicolini. Martinus Nijhoff, Boston 1988a; 733–738, In
   Google Scholar
• Skov K.A., Farrell N.P. Binding mode of 2-amino-5-nitrothiazole (ANT) in platinum complexes trans-[PtCl2(ANT)2] affects DNA binding, toxicity and radiosensitizing ability. International Journal of Radiation Biology 1987a; 52: 289–292
   Web of Science ®Google Scholar
• Skov K.A., Farrell N.P. Radiosensitization by complexes of lapachol. 35th Annual Meeting of the Radiation Research Society, Atlanta, 1987b, Abstract # Eh-7.
   Google Scholar
• Skov K.A., Farrell N.P., Adomat H. Further studies on nickel lapachol: a comparison with nitroimidazoles. 36th Annual Meeting of the Radiation Research Society, Philadelphia. Radiation Research Society, Philadelphia 1988b, Abstract Eh-8
   Google Scholar
• Skov K.A., Palcic B., Skarsgard L.D. Radiosensitization of mammalian cells by misonidazole and oxygen: DNA damage exposed by Micrococcus luteus enzymes. Radiation Research 1979; 79: 591–600
   PubMed Web of Science ®Google Scholar
• van Beusichem M., Farrell N. Activation of the trans geometry in platinum antitumor complexes. Synthesis, characterisation and biological activity of complexes with planar ligands pyridine, N-methylimidazole, thiazole and quinoline. The crystal and molecular structure of trans-dichlorobis (thiazole)platinum(II). Inorganic Chemistry 1992; 31: 634–639
   Web of Science ®Google Scholar
• Varnes M.E., Biaglow J.E., Koch C.J., Hall E.J. Depletion of nonprotein thiols of hypoxic cells by misonidazole and metronidazole. Radiation Sensitizers, L.W. Brady. Masson, New York 1980; 121–126, In
   Google Scholar
• White E.H., Bursey M.M. Chemiluminscence of luminol and related hydralazides: the light emission step. Journal of the American Chemical Society 1964; 86: 941–942
   Web of Science ®Google Scholar
• White E.H., Zafirious O., Kagi H.H., Hill J.H.M. Chemiluminescence of luminol: the chemical reaction. Journal of the American Chemical Society 1964; 86: 940–941
   Web of Science ®Google Scholar
• Wong T.W., Whitmore G.F., Gulyas S. Studies on the toxicity and radiosensitizing ability of misonidazole under conditions of prolonged incubation. Radiation Research 1978; 75: 541–555
   PubMed Web of Science ®Google Scholar